MAP1B and Alzheimer disease: Although three co-hub genes (GABBR2, MAP1B, and L1CAM) were identified, GABBR2 was prioritized due to its consistent diagnostic performance across datasets, specificity to AD, and its critical role in inhibitory neurotransmission and E/I balance.